| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $52,988 ) |
| | 2024 | 2024 | ACOUSTICABIO, INC. | 277 BROADWAY 1ST FL | CAMBRIDGE | MA | 02139-1807 | MIDDLESEX | USA | R43TR004761 | Enabling Subcutaneous Delivery of Therapeutic Monoclonal Antibodies via Hydrogel Microparticles | 000 | 1 | NIH | 2/23/2024 | $52,988 |
| | 2024 | 2023 | ACOUSTICABIO, INC. | 277 BROADWAY 1ST FL | CAMBRIDGE | MA | 02139-1807 | MIDDLESEX | USA | R43TR004761 | Enabling Subcutaneous Delivery of Therapeutic Monoclonal Antibodies via Hydrogel Microparticles | 001 | 1 | NIH | 9/3/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $324,500 ) |
| | 2023 | 2023 | ACOUSTICABIO, INC. | 277 BROADWAY 1ST FL | CAMBRIDGE | MA | 02139-1807 | MIDDLESEX | USA | R43TR004761 | Enabling Subcutaneous Delivery of Therapeutic Monoclonal Antibodies via Hydrogel Microparticles | 000 | 1 | NIH | 7/14/2023 | $324,500 |
|
|
